Detect, predict, and prevent acute seizures and status epilepticus
- PMID: 36871317
- DOI: 10.1016/j.yebeh.2023.109141
Detect, predict, and prevent acute seizures and status epilepticus
Abstract
Status epilepticus is one of the most frequent pediatric neurological emergencies. While etiology is often influencing the outcome, more easily modifiable risk factors of outcome include detection of prolonged convulsive seizures and status epilepticus and appropriately dosed and timely applied medication treatment. Unpredictability and delayed or incomplete treatment may at times lead to longer seizures, thereby affecting outcomes. Barriers in the care of acute seizures and status epilepticus include the identification of patients at greatest risk of convulsive status epilepticus, potential stigma, distrust, and uncertainties in acute seizure care, including caregivers, physicians, and patients. Furthermore, unpredictability, detection capability, and identification of acute seizures and status epilepticus, limitations in access to obtaining and maintaining appropriate treatment, and rescue treatment options pose challenges. Additionally, timing and dosing of treatment and related acute management algorithms, potential variations in care due to healthcare and physician culture and preference, and factors related to access, equity, diversity, and inclusion of care. We outline strategies for the identification of patients at risk of acute seizures and status epilepticus, improved status epilepticus detection and prediction, and acute closed-loop treatment and status epilepticus prevention. This paper was presented at the 8th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures held in September 2022.
Keywords: Detection; Prediction; Prevention; Status epilepticus; Treatment.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Tobias Loddenkemper is part of pending patent applications to detect and predict seizures and diagnose epilepsy. He receives research support from the NIH, the Epilepsy Research Fund, the Epilepsy Foundation of America Epilepsy Venture Fund (Shark Tank Award), MIKU, and Epitel. He received device donations from Epitel, MIKU, Empatica, and neuroelectrics. In the past, he received research grants from Sage, Lundbeck, Eisai, Upsher-Smith, Proximagen, UCB, Mallinckrodt, Pfizer, and Empatica. In the past, he served as a consultant for Engage and Upsher Smith.
Similar articles
-
Status epilepticus in pregnancy.Epilepsy Behav. 2023 Jan;138:109034. doi: 10.1016/j.yebeh.2022.109034. Epub 2022 Dec 14. Epilepsy Behav. 2023. PMID: 36525922 Review.
-
Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.Eur J Paediatr Neurol. 2012 Sep;16(5):536-41. doi: 10.1016/j.ejpn.2012.01.012. Epub 2012 Feb 11. Eur J Paediatr Neurol. 2012. PMID: 22326977 Clinical Trial.
-
Making SENSE of what we do - How to bring evidence to clinical practice.Epilepsy Behav. 2023 Mar;140:109103. doi: 10.1016/j.yebeh.2023.109103. Epub 2023 Feb 3. Epilepsy Behav. 2023. PMID: 36739635
-
The seventh London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures.Epilepsy Behav. 2019 Dec;101(Pt B):106532. doi: 10.1016/j.yebeh.2019.106532. Epub 2019 Nov 2. Epilepsy Behav. 2019. PMID: 31685383
-
Status epilepticus and acute serial seizures in children.J Child Neurol. 2002 Jan;17 Suppl 1:S36-43. doi: 10.1177/08830738020170010501. J Child Neurol. 2002. PMID: 11918461 Review.
Cited by
-
Unveiling the Multifaceted Problems Associated with Dysrhythmia.Int J Mol Sci. 2023 Dec 23;25(1):263. doi: 10.3390/ijms25010263. Int J Mol Sci. 2023. PMID: 38203440 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical